menu
    • menu

    Company profile for Shanghai Kechow Pharma

    NEW Drugs in Dev: 3
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    KeChow Pharma, Inc. is a biopharmaceutical company focused on novel drug discovery. The company has a high Ph.D. to staff ratio and operates facilities in Shanghai Zhangjiang High-Tech Park, and is recognized as a key bio-tech company by local government. The company’s strategy is to discover targeted small molecule drugs that have competitive advantages over existing therapies and co-develop the drugs with partners.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Shanghai Kechow PharmaChina Flag
    Country
    Country
    China
    Address
    Address
    Room 3M, No.780 Cailun Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shangha...
    Telephone
    Telephone
    +86-21-51323990
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://en.kechowpharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AACR Annual meeting

    AACR Annual meeting

    Not Confirmed

    envelop Contact Supplier

    AACR Annual meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    KeChow Pharma Announces NMPA Approval of Tunlametinib (HL-085)
    KeChow Pharma Announces NMPA Approval of Tunlametinib (HL-085)

    18 Mar 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kechow-pharma-announces-nmpa-approval-of-tunlametinib-hl-085-as-the-first-targeted-therapy-for-patients-with-nras-mutated-advanced-melanoma-and-previously-treated-with-pd-1pd-l1-302091342.html

    PR NEWSWIRE
    18 Mar 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search